MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aubrey, K. R.
Right arrow Articles by Vandenberg, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aubrey, K. R.
Right arrow Articles by Vandenberg, R. J.

Vol. 58, Issue 1, 129-135, July 2000

Molecular Basis for Proton Regulation of Glycine Transport by Glycine Transporter Subtype 1b

Karin R. Aubrey, Ann D. Mitrovic, and Robert J. Vandenberg

Department of Pharmacology, University of Sydney, Sydney, New South Wales, Australia

In the central nervous system, glycine is a coagonist with glutamate at the N-methyl-D-aspartate subtype of ionotropic glutamate receptors. The GLYT1b subtype of glycine transporters is expressed in similar regions of the brain as the excitatory N-methyl-D-aspartate receptors and has been postulated to regulate glycine concentrations within excitatory synapses. We have expressed GLYT1b in Xenopus laevis oocytes and used electrophysiological techniques to investigate the pH regulation of glycine transporter function. We found that H+ inhibits glycine transport by a noncompetitive mechanism, with half-maximal inhibition occurring at concentrations found in both physiological and pathological conditions. Charge-to-flux experiments revealed that the decreased current measured corresponds to a decreased influx of [3H]glycine and that the proton inhibition of GLYT1b does not alter the coupling ratio of transport. The membrane potential does not affect proton inhibition of transport, suggesting that the site of action on GLYT1b is not within the electric field of the membrane. Mutation of histidine 421 to an alanine residue, in the fourth extracellular loop of GLYT1b, renders the transporter insensitive to regulation by pH, but does not seem to alter the kinetics of glycine transport. These results suggests that histidine 421 is responsible for mediating the inhibitory actions of protons. Proton modulation of GLYT1b may be an important factor in determining the dynamics of excitatory neurotransmission.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
IOVSHome page
J. Lim, L. Li, M. D. Jacobs, J. Kistler, and P. J. Donaldson
Mapping of Glutathione and Its Precursor Amino Acids Reveals a Role for GLYT2 in Glycine Uptake in the Lens Core
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5142 - 5151.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Vandenberg, K. Shaddick, and P. Ju
Molecular Basis for Substrate Discrimination by Glycine Transporters
J. Biol. Chem., May 11, 2007; 282(19): 14447 - 14453.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Iwamoto, R. D. Blakely, and L. J. De Felice
Na+, Cl-, and pH Dependence of the Human Choline Transporter (hCHT) in Xenopus Oocytes: The Proton Inactivation Hypothesis of hCHT in Synaptic Vesicles
J. Neurosci., September 27, 2006; 26(39): 9851 - 9859.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
K. R. Aubrey, R. J. Vandenberg, and J. D. Clements
Dynamics of Forward and Reverse Transport by the Glial Glycine Transporter, Glyt1b
Biophys. J., September 1, 2005; 89(3): 1657 - 1668.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Ju, K. R. Aubrey, and R. J. Vandenberg
Zn2+ Inhibits Glycine Transport by Glycine Transporter Subtype 1b
J. Biol. Chem., May 28, 2004; 279(22): 22983 - 22991.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics